Meet The Professors:
Recorded in Miami, Florida, September 29, 2005

FACULTY
	Peter C Enzinger, MD Instructor in Medicine Harvard Medical School Clinical Director Gastrointestinal Cancer Center Dana-Farber Cancer Institute Boston, Massachusetts		George A Fisher, MD, PhD Associate Professor of Medicine (Oncology) Stanford University School of Medicine Director, Clinical Trials Office Stanford University Cancer Center Stanford, California
	Robert A Wolff, MD Associate Professor of Medicine Deputy Chairman for Clinical Affairs Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston, Texas
Medical Oncologist Community Panel
Barbara G Fallon, MD New Britton, Connecticut Giuseppe Fraschini, MD, FACP Houston, Texas Robert Goldberg, MD Pomana, New York Ghassan Jano, MD Munster, Indiana Kapisthalam S Kumar, MD, FACP New Port Richie, Florida		Fernando T Miranda, MD Nashville, Tennessee Daniel J Moriarty, MD Short Hills, New Jersey William G Reeves, MD Youngstown, Ohio Gary A Steinecker, MD Oak Lawn, Illinois Doron Weiner, MD Merrick, New York

Content Validation and Disclosures

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr Enzinger — Consulting Fees: Daiichi Pharmaceutical Co Ltd, Genentech BioOncology, Pfizer Inc, Sanofi-Aventis. Dr Fisher — Consulting Fees: Bristol-Myers Squibb Company, Genentech BioOncology, Pfizer Inc, Sanofi-Aventis; Honorarium: Roche Laboratories Inc; Research Support: Bristol-Myers Squibb Company, Novartis Pharmaceuticals, Pfizer Inc. Dr Wolff — Consulting Fees: Eli Lilly and Company, Pfizer Inc.

The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process: Terry Ann Glauser, MD, MPH, Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Michelle Paley, MD, Margaret Peng, Lilliam Sklaver Poltorack, PharmD and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc. Research To Practice receives education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Biogen Idec, Genentech BioOncology, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.